BWX Technologies
BWXT
$210.94
+1.99%
BWX Technologies, Inc. is a specialty manufacturer and service provider of nuclear components, operating primarily in the Aerospace & Defense industry. The company is a critical, sole-source supplier to the U.S. Naval Nuclear Propulsion Program and a key player in the commercial nuclear power supply chain, distinguishing itself as a high-barrier-to-entry, mission-critical contractor with a near-monopoly in naval reactor production. The current investor narrative is driven by robust backlog growth and geopolitical tailwinds for defense spending, as evidenced by recent record earnings, but is tempered by market concerns over execution risks associated with its strategic expansion into commercial nuclear capacity through acquisitions.…
BWXT
BWX Technologies
$210.94
Related headlines
Investment Opinion: Should I buy BWXT Today?
Rating & Thesis: Hold. BWXT is a high-quality company with a superb competitive position and strong fundamentals, but its extreme valuation following a 95% one-year rally leaves minimal margin for error and limited near-term upside, aligning with the mixed 'Buy' and 'Hold' analyst consensus.
Supporting Evidence: The stock trades at a forward PE of 41.85x, a steep premium to the industrial sector. While revenue growth is robust at 18.7% YoY and profitability is excellent (26.75% ROE, 10.5% net margin), the implied 31% upside to the analyst target of ~$283 is contingent on maintaining these premium multiples. The stock's technical position is extended, trading near its 52-week high after a massive run, and recent relative strength has turned negative. Strong free cash flow generation ($295M TTM) and a solid current ratio (2.32) provide financial stability.
Risks & Conditions: The two biggest risks are valuation multiple contraction and commercial segment execution missteps. This Hold rating would upgrade to a Buy if the forward PE compresses toward 30x without a deterioration in the growth outlook (providing a better entry point), or if the company demonstrates flawless integration of its commercial acquisitions leading to upward EPS revisions. It would downgrade to a Sell if revenue growth decelerates below 10% or net margins contract significantly, triggering the feared multiple compression. Based on current data, the stock is overvalued relative to its historical range and sector peers, but fairly valued relative to its own elevated growth trajectory and analyst expectations.
Sign up to view all
BWXT 12-Month Price Forecast
The outlook for BWXT is a classic case of superb fundamentals meeting demanding valuation. The base case (60% probability) of steady execution and target achievement is most likely, but the risk/reward is balanced given the stock's elevated starting point. The bull case requires sustained perfection to justify further multiple expansion, while the bear case, though lower probability, carries a sharp downside to the $170s if the growth narrative cracks. The stance is neutral; the stock is a 'show me' story at these levels. Upgrading to bullish would require evidence that commercial segment growth is accelerating without margin sacrifice, providing a new leg to the growth story. Downgrading to bearish would be triggered by any material deceleration in the core government revenue growth or a breakdown below key technical support at $178.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on BWX Technologies's 12-month outlook, with a consensus price target around $274.22 and implied upside of +30.0% versus the current price.
Average Target
$274.22
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$169 - $274
Analyst target range
Analyst coverage for BWXT is limited, with only 6 analysts providing estimates, which is typical for a mid-cap, specialized industrial company. The consensus sentiment leans bullish, as evidenced by recent institutional ratings from firms like B of A Securities and BTIG maintaining 'Buy' ratings, though others like Deutsche Bank and Truist Securities have 'Hold' stances. The average target price must be inferred from estimated EPS and the forward PE; using the forward PE of 41.85x and the estimated EPS average of $6.77 implies a consensus price target of approximately $283, which would represent a significant 31% upside from the current price of $216.31. The target range, derived from estimated EPS, shows a low of $6.62 and a high of $7.20. Applying the forward PE multiple, this translates to a price range of roughly $277 to $301. The high target assumes flawless execution on backlog conversion, margin expansion, and successful commercial segment growth. The low target likely factors in potential cost overruns, program delays, or a less favorable defense budget environment. The relatively tight range between the high and low EPS estimates suggests analysts have a reasonable degree of conviction in the near-term earnings trajectory. The pattern of recent institutional ratings shows stability, with no downgrades in the provided data and several reiterated Buy ratings, indicating sustained analyst confidence following strong quarterly results.
Bulls vs Bears: BWXT Investment Factors
The bull case for BWXT is compelling, anchored in its irreplaceable monopoly position within the U.S. naval nuclear program, accelerating revenue growth (18.7% YoY), and exceptional profitability (26.75% ROE). However, the bear case presents a formidable counter-argument centered on an extreme valuation premium (47.98x trailing PE) that prices in perfection, leaving no margin for error. Currently, the bullish fundamentals of growth, backlog, and analyst targets provide stronger evidence, but the stock's massive run has fully discounted this optimism. The single most important tension in the investment debate is whether BWXT's unique, non-cyclical government revenue stream and growth trajectory can justify and sustain its sky-high valuation multiple in the face of execution risks associated with its commercial expansion. The resolution of this tension—through either flawless execution and continued beat-and-raise quarters or any sign of stalling growth—will dictate the stock's direction.
Bullish
- Monopoly Naval Business & Geopolitical Tailwinds: As the sole-source supplier to the U.S. Naval Nuclear Propulsion Program, BWXT operates a mission-critical, high-barrier-to-entry monopoly. This is underpinned by a 50% backlog growth reported in Q1 2026, securing multi-year revenue visibility. Geopolitical tensions, as highlighted by recent defense stock rallies, provide a durable tailwind for this core government segment.
- Accelerating Revenue & Strong Profitability: Q4 2025 revenue grew 18.7% YoY to $885.8 million, with sequential growth throughout the year. The company is highly profitable, with a net margin of 10.5% and an exceptional Return on Equity of 26.75%, indicating superior capital efficiency and the ability to fund growth internally.
- Significant Analyst Upside & Bullish Sentiment: The implied analyst consensus price target is approximately $283, representing a 31% upside from the current price of $216.31. Recent institutional ratings from B of A Securities and BTIG maintain 'Buy' stances, reflecting confidence following strong quarterly results and the robust backlog.
- Strong Cash Flow Generation & Liquidity: The company generates substantial free cash flow, with TTM FCF of $295.3 million, providing a buffer for its strategic expansion. Liquidity is strong with a current ratio of 2.32, ensuring operational flexibility despite an elevated debt-to-equity ratio of 1.64.
Bearish
- Extreme Valuation Premium & Multiple Risk: BWXT trades at a trailing PE of 47.98x and a forward PE of 41.85x, a significant premium to typical industrial/defense multiples. The current PE is near its historical high of 51.40x, leaving the stock vulnerable to severe multiple contraction if growth expectations falter or execution stumbles.
- Execution Risk in Commercial Expansion: The stock recently declined on news of an acquisition to expand commercial nuclear capacity, as the market focuses on near-term integration and execution risks. This strategic pivot into the commercial sector, while a long-term opportunity, introduces new operational complexities away from its core government monopoly.
- Technical Overextension & Momentum Decay: After a 94.66% one-year surge, the stock is trading 89% of the way from its 52-week low to its high, signaling potential overextension. Recent momentum has decayed, with the stock underperforming the S&P 500 over 1 month (-8.34% relative strength), suggesting a consolidation or rotation phase.
- Leveraged Balance Sheet: The company's debt-to-equity ratio of 1.64 indicates significant reliance on debt financing. While strong cash flow mitigates this risk, it limits financial flexibility and increases sensitivity to rising interest rates or any downturn in cash generation.
BWXT Technical Analysis
The stock is in a sustained, powerful uptrend, evidenced by a staggering 94.66% one-year price appreciation. As of the latest close at $216.31, the stock is trading near the top of its 52-week range, approximately 89% of the way from its low of $102.42 to its high of $241.82, indicating strong momentum but also potential overextension relative to its recent trading band. This positioning suggests the market is pricing in significant growth expectations, leaving the stock vulnerable to any disappointment. Recent momentum shows a deceleration from the torrid long-term pace, with a 1-month gain of 1.64% and a 3-month gain of 5.30%, which underperforms the S&P 500's 9.98% and 4.14% gains over the same periods, respectively, as shown by relative strength figures of -8.34 and +1.16. This divergence signals a potential consolidation or rotation out of the stock after its massive run, as near-term buyers pause. Key technical support is anchored at the 52-week low of $102.42, though a more relevant near-term floor is likely around the $169-$178 zone seen in late 2025. Immediate resistance is at the 52-week high of $241.82; a decisive breakout above this level would signal a resumption of the primary bull trend, while a failure could lead to a deeper correction. The stock exhibits lower volatility than the broader market, with a beta of 0.794, meaning it is about 21% less volatile than the SPY, which is notable for a defense contractor and suggests its price movements are somewhat insulated from general market swings, though subject to its own fundamental and geopolitical catalysts. The price action over the provided 180-day period shows a volatile climb from around $170 in December 2025 to a peak near $238 in April 2026, followed by a recent pullback. The 22.12% maximum drawdown figure indicates the stock has experienced significant intra-period volatility despite the strong net gain. Volume data shows an average of 609,184 shares, and the elevated short ratio of 3.13 suggests a notable bearish contingent that could fuel a short-covering rally on positive news, but also reflects skepticism at current valuation levels.
Beta
0.78
0.78x market volatility
Max Drawdown
-22.1%
Largest decline past year
52-Week Range
$106-$242
Price range past year
Annual Return
+96.9%
Cumulative gain past year
| Period | BWXT Return | S&P 500 |
|---|---|---|
| 1m | -11.5% | +7.7% |
| 3m | +5.3% | +9.7% |
| 6m | +18.3% | +11.3% |
| 1y | +96.9% | +27.3% |
| ytd | +16.0% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BWXT Fundamental Analysis
Revenue growth is robust and accelerating. For Q4 2025, revenue reached $885.8 million, representing a significant 18.7% year-over-year growth. Segment data reveals the Government Operations segment, at $589.1 million, is the primary driver, constituting roughly two-thirds of total revenue, while the Commercial Operations segment contributed $297.7 million. The multi-quarter trend shows consistent sequential revenue increases from $682.3 million in Q1 2025 to the Q4 level, indicating strong execution and demand across its contract portfolio. The company is solidly profitable with expanding margins. Q4 2025 net income was $93.0 million, yielding a net margin of 10.5%. Gross margin for the quarter was 21.0%, while the trailing twelve-month gross margin stands at 22.9%. Operating margin for Q4 was 8.1%. Comparing to the prior-year Q4, net margin improved from 9.5% to 10.5%, and gross margin declined slightly from 23.4% to 21.0%, suggesting a mix shift or cost pressures that were more than offset by operating leverage elsewhere. The company's return on equity is exceptionally strong at 26.75%, highlighting efficient use of shareholder capital. Balance sheet health is adequate but leveraged. The debt-to-equity ratio is elevated at 1.64, indicating a significant reliance on debt financing. However, liquidity is strong with a current ratio of 2.32. The company generates substantial cash flow, with TTM free cash flow of $295.3 million. Return on Assets is a healthy 5.95%. The combination of strong profitability, high ROE, and solid free cash flow generation provides the company with internal resources to fund growth and service its debt, mitigating the risks associated with its leveraged balance sheet.
Quarterly Revenue
$885815000.0B
2025-12
Revenue YoY Growth
+0.18%
YoY Comparison
Gross Margin
+0.20%
Latest Quarter
Free Cash Flow
$295291000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BWXT Overvalued?
Given the company's consistent profitability with positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 47.98x, while the forward PE is lower at 41.85x. The gap between trailing and forward multiples implies analysts expect earnings growth, with forward EPS estimates averaging $6.77, suggesting a moderation from the current high multiple as profits are projected to increase. Compared to sector averages, BWXT trades at a significant premium. Its trailing PE of 47.98x and forward PE of 41.85x are well above typical industrial or defense contractor multiples, which often range in the low-to-mid 20s. The Price-to-Sales ratio of 4.95x and EV/EBITDA of 31.44x further confirm this premium valuation. This premium is likely justified by the company's unique, non-cyclical government revenue stream, high barriers to entry, superior growth profile (18.7% YoY revenue growth), and exceptional profitability metrics like its 26.75% ROE. Historically, the stock's valuation is near the upper end of its own range. The current trailing PE of 47.98x is above the historical PE ratios visible in the data, which have fluctuated between approximately 9.44x in late 2021 and 51.40x in Q3 2025. Trading near historical highs suggests the market is pricing in very optimistic expectations for sustained growth and margin performance. Any deviation from this optimistic path could lead to substantial multiple contraction, given the elevated starting point.
PE
48.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~51x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
31.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks stem primarily from BWXT's leveraged capital structure, with a debt-to-equity ratio of 1.64, which could pressure earnings if interest rates remain elevated. While TTM free cash flow of $295.3 million provides a cushion, the company's strategic expansion into commercial nuclear via acquisitions introduces integration and execution risks, as evidenced by the stock's negative reaction to a recent deal announcement. Furthermore, revenue concentration is a key risk, with the Government Operations segment constituting roughly two-thirds of total revenue, creating dependency on U.S. defense budgets and the timing of naval contracts.
Market & Competitive Risks are dominated by valuation compression. Trading at a trailing PE of 47.98x and an EV/EBITDA of 31.44x—a substantial premium to sector peers—the stock is highly susceptible to a derating if growth decelerates or market sentiment shifts away from premium-priced industrials. The stock's beta of 0.794 suggests it is less volatile than the market, but this low correlation could break down if a sector-wide rotation out of high-multiple stocks occurs. Competitive risks in its commercial segment are real, as highlighted by the struggles of peers like NuScale Power, though BWXT's government monopoly provides a defensive moat.
Worst-Case Scenario involves a combination of execution missteps in commercial expansion, cost overruns on key government contracts, and a broader market multiple compression for growth industrials. This could trigger analyst downgrades, a loss of investor confidence, and a rapid unwinding of the valuation premium. The realistic downside could see the stock re-test its recent significant support zone around $169-$178, representing a decline of 18-22% from the current price. A more severe bear case, aligning with the 52-week low of $102.42, seems less probable barring a catastrophic company-specific failure, but a drop to the $170s is a quantifiable risk from current levels.
FAQ
The key risks are: 1) Valuation Compression: The primary risk is the high PE multiple (47.98x trailing). If growth decelerates or market sentiment sours, the multiple could contract rapidly. 2) Execution & Integration: The commercial expansion through acquisitions introduces integration risks, as seen in the stock's negative reaction to a recent deal. 3) Financial Leverage: A debt-to-equity ratio of 1.64 increases interest expense sensitivity and reduces financial flexibility. 4) Revenue Concentration: Approximately two-thirds of revenue comes from the U.S. Government, creating dependency on defense budgets and contract timing. Valuation risk is currently the most severe due to the stock's extended price.
The 12-month forecast presents three scenarios. The Base Case (60% probability) targets $277-$283, assuming the company meets consensus EPS of $6.77 and maintains its current forward PE multiple near 42x. The Bull Case (25% probability) targets $277-$301, requiring flawless execution, margin expansion, and multiple expansion. The Bear Case (15% probability) sees a correction to the $169-$178 support zone on an earnings disappointment or derating event. The most likely outcome is the Base Case, tracking analyst targets, but the path will be volatile and highly sensitive to quarterly earnings reports and guidance.
BWXT is overvalued on an absolute and relative basis but may be fairly valued based on its unique growth profile. Its trailing PE of 47.98x and forward PE of 41.85x are at the upper end of its own historical range and command a large premium to the broader industrials sector. This premium reflects its monopoly position, 18.7% revenue growth, and 26.75% ROE. The valuation implies the market expects near-flawless execution and sustained high growth. Any stumble would likely cause a sharp derating. Therefore, while the price may be justified by its fundamentals, it leaves no safety margin, making it vulnerable to overvaluation if growth slows.
BWXT is a good stock for investors who already have a position and believe in the long-term nuclear and defense thesis, but it is a challenging buy at current prices for new money. The implied 31% upside to analyst targets is attractive, but it is contingent on maintaining a lofty forward PE of 41.85x. The stock has already surged 95% in a year, pricing in significant optimism. It is a good buy for patient, long-term investors on a meaningful pullback (e.g., towards $180-$190), where the valuation risk is reduced. For those seeking immediate entry, the risk of multiple compression outweighs the near-term reward.
BWXT is primarily suitable for a long-term investment horizon of 3-5 years. Its business model is based on multi-year government contracts and a long-term nuclear energy thesis, not short-term catalysts. While the stock has a beta of 0.79, indicating lower volatility than the market, its high valuation and recent run-up make it prone to sharp corrections on any negative news, rendering it risky for short-term trading. The low dividend yield of 0.58% also makes it unsuitable for income seekers. Long-term investors can better weather the volatility and benefit from the company's entrenched market position and growth initiatives in commercial nuclear.

